Overview
Management Team
Board of Directors
Clinical Advisory Board
Picoplatin Overview
Picoplatin Value
Proposition
Colorectal Cancer
Prostate Cancer
Ovarian Cancer
Small Cell Lung Cancer
Overview
Annual Repoort
SEC Filings
Stock Information
News Releases
Event Calendar
Presentations and
Publications
Shareholder Services
Corporate Governance
Locations
Corporate
Communications &
Investor Relations
Business Development
Locations
Corporate Communications & Investor Relations
Business Development
Corporate Communications & Investor Relations
Susan Neath
WCG
Email:
sneath@wcgworld.com
Phone: 212-301-7182
About Poniard
|
Picoplatin Overview & Market Opportunities
|
Investors
|
Contact Us
© 2010 Poniard Pharmaceuticals.
Corporate Governance
|
Site Users Guide
